A PYMNTS Company

US/Canada: Botox maker receives sweetened takeover bid

By  |  May 28, 2014

Valeant Pharmaceuticals has reportedly upped its unsolicited offer to acquire the maker of Botox.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Reports say Valeant increased its bid to $49.4 billion to acquire Canada-based Allergan in hopes of swaying approval from the firm and its shareholders. The original acquisition offer was first introduced last month.

    The deal is reportedly part of Valeant’s efforts to become one of the world’s five largest pharmaceutical firms by 2017.

    Full content: Bloomberg

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.